4301

Targeted Epigenomic (methylation) alterations by CRISPR/Cas9 technology

Hellman Asaf, HUJI, School of Medicine - IMRIC, Developmental Biology and Cancer Research
Meron Nurit, HUJI, School of Medicine - IMRIC
Additional information will be provided upon request

Patent Status

Published WO2017/208247

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
+972-2-6586608
Contact ME:
Image CAPTCHA